Silicon

DB12982ApprovedSmall molecule

Silicon is a micronutrient indicated in nutritional products to treat or prevent silicon deficiencies. Silicon is under investigation in clinical trial NCT00103246 (Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides).

Chemical structure of Silicon
Formula / weight
Si · 28.085 g/mol (avg)
First approval
Canada, 1996

Resolves to

Compound
UNIIZ4152N8IUICAS7440-21-3ChEBI27573PubChem5461123
Clinical / RWD
RxNorm9774
Structure
InChIKeyXUIMIQQOPSSXEZ-UHFFFAOYSA-NSMILES[Si]
Transporters
Q92482AQP3O14520AQP7O43315AQP9Q96PS8AQP10

What you can answer from here — as of September 24, 2026

4TransportersSubstrate / inhibitor direction, not just membership
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
41Marketed productsAcross 4 countries and 25 labellers
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Silicon, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In